Skip to content
HowShorted

Prestige Consumer Healthcare Inc. short interest in 2018

In 2018, Prestige Consumer Healthcare Inc.'s disclosed short interest ran from 13.31% of shares outstanding on 12 Jan 2018 to 19.29% on 31 Dec 2018, a change of +5.98 percentage points. The year's high was 21.32% on 28 Sep 2018 and its low 13.31% on 12 Jan 2018, averaging 17.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 27.77 days on 30 Nov 2018. Full history: Prestige Consumer Healthcare Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Prestige Consumer Healthcare Inc. in 2018

2018 in figures

Start of year
13.31% (12 Jan 2018)
End of year
19.29% (31 Dec 2018)
Change
+5.98 pp
High
21.32% (28 Sep 2018)
Low
13.31% (12 Jan 2018)
Average
17.18%
Highest days to cover
27.77 (30 Nov 2018)
SEC filings marked
8

Every report in 2018

Prestige Consumer Healthcare Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201813.31%11.97
31 Jan 201814.06%11.99
15 Feb 201813.35%4.4810-Q filed, results (8-K)
28 Feb 201814.90%10.51
15 Mar 201813.61%12.45
29 Mar 201815.53%10.73
13 Apr 201814.86%10.45
30 Apr 201815.46%13.17
15 May 201815.28%5.3010-K filed, results (8-K)
31 May 201815.84%8.55
15 Jun 201816.14%13.63
29 Jun 201817.04%10.80
13 Jul 201816.88%23.06
31 Jul 201818.83%19.45
15 Aug 201820.16%17.6210-Q filed, results (8-K)
31 Aug 201819.25%23.97
14 Sep 201820.45%20.94
28 Sep 201821.32%19.71
15 Oct 201820.20%25.18
31 Oct 201819.35%16.17
15 Nov 201818.49%16.3510-Q filed, results (8-K)
30 Nov 201819.40%27.77
14 Dec 201819.24%20.53
31 Dec 201819.29%19.35

See also: Prestige Consumer Healthcare Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.